Hadas Gibori

1.1k total citations
10 papers, 538 citations indexed

About

Hadas Gibori is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hadas Gibori has authored 10 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hadas Gibori's work include RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Hadas Gibori is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), MicroRNA in disease regulation (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Hadas Gibori collaborates with scholars based in Israel, United States and Italy. Hadas Gibori's co-authors include Iris Barshack, Ronit Satchi‐Fainaro, Shlomit Gilad, Galia Tiram, Dikla Ben‐Shushan, Eti Meiri, Zvi Bentwich, Shai Rosenwald, Nitzan Rosenfeld and Ranit Aharonov and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Plant Journal.

In The Last Decade

Hadas Gibori

10 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadas Gibori Israel 8 377 316 102 47 34 10 538
Valentina Angeloni Italy 8 302 0.8× 247 0.8× 48 0.5× 62 1.3× 49 1.4× 10 435
Yuancai Xie China 13 360 1.0× 268 0.8× 114 1.1× 105 2.2× 66 1.9× 25 539
Qiou Gu China 9 521 1.4× 380 1.2× 60 0.6× 94 2.0× 18 0.5× 10 603
Yingying Jiang China 13 406 1.1× 338 1.1× 84 0.8× 80 1.7× 15 0.4× 33 549
Zhiwei Qiao Japan 13 210 0.6× 130 0.4× 141 1.4× 111 2.4× 37 1.1× 33 428
Qiong‐Cong Xu China 13 543 1.4× 321 1.0× 54 0.5× 126 2.7× 32 0.9× 29 661

Countries citing papers authored by Hadas Gibori

Since Specialization
Citations

This map shows the geographic impact of Hadas Gibori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadas Gibori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadas Gibori more than expected).

Fields of papers citing papers by Hadas Gibori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadas Gibori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadas Gibori. The network helps show where Hadas Gibori may publish in the future.

Co-authorship network of co-authors of Hadas Gibori

This figure shows the co-authorship network connecting the top 25 collaborators of Hadas Gibori. A scholar is included among the top collaborators of Hadas Gibori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadas Gibori. Hadas Gibori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Malfanti, Alessio, Anna Scomparin, Sabina Pozzi, et al.. (2019). Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery. Journal of Controlled Release. 310. 58–73. 9 indexed citations
2.
Krivitsky, Adva, Vadim Krivitsky, Dina Polyak, et al.. (2018). Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers. Polymers. 10(5). 548–548. 7 indexed citations
3.
Gibori, Hadas, Adva Krivitsky, Dikla Ben‐Shushan, et al.. (2017). Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nature Communications. 9(1). 16–16. 79 indexed citations
5.
Ben‐Shushan, Dikla, Ela Markovsky, Hadas Gibori, et al.. (2013). Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Delivery and Translational Research. 4(1). 38–49. 53 indexed citations
6.
Gilad, Shlomit, Gila Lithwick‐Yanai, Iris Barshack, et al.. (2012). Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay. Journal of Molecular Diagnostics. 14(5). 510–517. 96 indexed citations
7.
Purim, Ofer, Michal Kushnir, Gila Lithwick‐Yanai, et al.. (2012). Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.. Journal of Clinical Oncology. 30(15_suppl). e14067–e14067. 16 indexed citations
8.
Benjamin, Hila, Danit Lebanony, Shai Rosenwald, et al.. (2010). A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma. Journal of Molecular Diagnostics. 12(6). 771–779. 86 indexed citations
9.
Benjamin, H., Danit Lebanony, Sarit Tabak, et al.. (2009). MicroRNA-based assay for differential diagnosis of mesothelioma. Journal of Clinical Oncology. 27(15_suppl). e22079–e22079. 1 indexed citations
10.
Nass, Dvora, Shai Rosenwald, Eti Meiri, et al.. (2008). MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors. Brain Pathology. 19(3). 375–383. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026